Welcome to our dedicated page for Hudson Acquisition I news (Ticker: HUDAU), a resource for investors and traders seeking the latest updates and insights on Hudson Acquisition I stock.
Hudson Acquisition I Corp. reports SPAC-related corporate developments centered on shareholder votes, material agreements, governance actions and capital-structure disclosures. Recurring updates address the blank-check issuer's security structure, including units, rights and common stock, as well as voting mechanics and other matters tied to its role as a company formed to pursue a business combination.
Hudson Acquisition I Corp. (Nasdaq: HUDA) has announced a letter of intent (LOI) for a potential merger with a pre-clinical-stage biotechnology firm focused on developing intranasal preventives for respiratory viruses. The LOI outlines preliminary terms but is not binding, with the acquisition contingent on various factors including board approvals and satisfactory due diligence. The restructuring will see new executive appointments at Hudson. A definitive agreement is necessary before a registration statement on Form S-4 is filed with the SEC, which would include a Proxy Statement for stockholder approval. Completion of the deal, however, is uncertain.
Hudson Acquisition I Corp. (HUDA) has announced it has regained compliance with Nasdaq Listing Rule 5250(c)(1). This follows a notice of noncompliance received on December 9, 2022, due to the late filing of its quarterly report for Q3 2022. The company filed its 10-Q on December 21, 2022, which led to Nasdaq's confirmation of compliance on December 27, 2022. As a blank check company, HUDA aims to engage in business combinations across various industries, excluding entities with significant operations in China.
Hudson Acquisition I Corp. (HUDA) announced on December 9, 2022, that it is out of compliance with Nasdaq Listing Rule 5250(c)(1) due to the late filing of its quarterly report for Q3 2022. The company must submit a plan to regain compliance within 60 days, potentially receiving an extension until May 29, 2023, if accepted. Despite the notice, there will be no immediate impact on the trading of HUDA shares. Management is actively working to file the 10-Q as soon as possible.
Hudson Acquisition I Corp. (NASDAQ: HUDA) has successfully closed its initial public offering (IPO) of 6,000,000 units at $10.00 per unit, totaling $60 million. The units began trading on NASDAQ under the symbol HUDAU on October 14, 2022. Each unit comprises one share of common stock and a right to receive one-fifth of a share upon a business combination. Underwriters have a 45-day option to purchase an additional 900,000 units. The company plans to engage in a merger or similar business combination, excluding entities based in China.
Hudson Acquisition I Corp. (NASDAQ: HUDA) announced the pricing of its initial public offering (IPO) of 6,000,000 units at $10.00 per unit, set to begin trading on October 14, 2022. Each unit includes one share of common stock and a right to receive one-fifth of a share upon a business combination. The offering, managed by Chardan Capital Markets, includes a 45-day over-allotment option for up to 900,000 additional units. Expected closing is on October 18, 2022, subject to customary conditions.